These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9041331)

  • 1. Selection of glycopeptide-resistant mutants of VanB-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis.
    Aslangul E; Baptista M; Fantin B; Depardieu F; Arthur M; Courvalin P; Carbon C
    J Infect Dis; 1997 Mar; 175(3):598-605. PubMed ID: 9041331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis.
    Lefort A; Baptista M; Fantin B; Depardieu F; Arthur M; Carbon C; Courvalin P
    Antimicrob Agents Chemother; 1999 Mar; 43(3):476-82. PubMed ID: 10049254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
    Lefort A; Arthur M; Depardieu F; Chau F; Pouzet C; Courvalin P; Fantin B
    J Infect Dis; 2004 Jan; 189(1):90-7. PubMed ID: 14702158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis.
    Saleh-Mghir A; Lefort A; Petegnief Y; Dautrey S; Vallois JM; Le Guludec D; Carbon C; Fantin B
    Antimicrob Agents Chemother; 1999 Jan; 43(1):115-20. PubMed ID: 9869575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis.
    Baptista M; Depardieu F; Courvalin P; Arthur M
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2291-5. PubMed ID: 8891132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Lafaurie M; Perichon B; Lefort A; Carbon C; Courvalin P; Fantin B
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis.
    Nicolau DP; Marangos MN; Nightingale CH; Patel KB; Cooper BW; Quintiliani R; Courvalin P; Quintiliani R
    Antimicrob Agents Chemother; 1996 Jan; 40(1):55-60. PubMed ID: 8787879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium.
    Lefort A; Garry L; Depardieu F; Courvalin P; Fantin B
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3515-8. PubMed ID: 14576110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell analysis of glycopeptide resistance gene expression in teicoplanin-resistant mutants of a VanB-type Enterococcus faecalis.
    Baptista M; Rodrigues P; Depardieu F; Courvalin P; Arthur M
    Mol Microbiol; 1999 Apr; 32(1):17-28. PubMed ID: 10216856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.
    Fraise AP; Andrews J; Wise R
    J Antimicrob Chemother; 1997 Sep; 40(3):423-5. PubMed ID: 9338497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.
    Kolár M; Vágnerová I; Látal T; Kohnová I
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():69-71. PubMed ID: 10743728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci.
    Kirk M; Hill RL; Casewell MW; Beighton D
    Adv Exp Med Biol; 1997; 418():483-5. PubMed ID: 9331699
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis.
    Lefort A; Saleh-Mghir A; Garry L; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3017-21. PubMed ID: 11036016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants.
    Van Bambeke F; Chauvel M; Reynolds PE; Fraimow HS; Courvalin P
    Antimicrob Agents Chemother; 1999 Jan; 43(1):41-7. PubMed ID: 9869563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583.
    Evers S; Courvalin P
    J Bacteriol; 1996 Mar; 178(5):1302-9. PubMed ID: 8631706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype.
    Kawalec M; Gniadkowski M; Kedzierska J; Skotnicki A; Fiett J; Hryniewicz W
    J Clin Microbiol; 2001 Dec; 39(12):4274-82. PubMed ID: 11724832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci.
    Gold HS; Unal S; Cercenado E; Thauvin-Eliopoulos C; Eliopoulos GM; Wennersten CB; Moellering RC
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1604-9. PubMed ID: 8215270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405.
    Fines M; Perichon B; Reynolds P; Sahm DF; Courvalin P
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2161-4. PubMed ID: 10471558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.